title: First in class, potent, and orally bioavailable NADPH oxidase isoform 4 (Nox4) inhibitors for the treatment of idiopathic pulmonary fibrosis.
authors.affiliation: Genkyotex, S.A., 14 Chemin des Aulx, CH-1228 Plan-Les-Ouates, Switzerland.
authors.forename: Benoît
authors.initials: B
authors.lastname: Laleu
authors.forename: Francesca
authors.initials: F
authors.lastname: Gaggini
authors.forename: Mike
authors.initials: M
authors.lastname: Orchard
authors.forename: Laetitia
authors.initials: L
authors.lastname: Fioraso-Cartier
authors.forename: Laurène
authors.initials: L
authors.lastname: Cagnon
authors.forename: Sophie
authors.initials: S
authors.lastname: Houngninou-Molango
authors.forename: Angelo
authors.initials: A
authors.lastname: Gradia
authors.forename: Guillaume
authors.initials: G
authors.lastname: Duboux
authors.forename: Cédric
authors.initials: C
authors.lastname: Merlot
authors.forename: Freddy
authors.initials: F
authors.lastname: Heitz
authors.forename: Cédric
authors.initials: C
authors.lastname: Szyndralewiez
authors.forename: Patrick
authors.initials: P
authors.lastname: Page